News
After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in pharmaceutical innovation. President Colin Murdoch revealed the company's ...
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.
Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...
Researchers are urging developers to prioritize research into “chain-of-thought” processes, which provide a window into how ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...
An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results